SDGR FINANCIAL STATEMENTS

Schrodinger Inc — balance sheet, income statement and cash flow trends

SDGRSchrodinger Inc

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue254.9 M $+10.6%

Gross Profit141 M $-2.3%

Operating Income-164.8 M $—

EBITDA-94.6 M $—

Net Income-103.5 M $—

Peer Comparison· Health Information Services

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
SDGR	10.6%	55.3%	-37.1%	-40.6%
MSB	410.4%	-32.0%	-76.6%	-115.3%
BHC	-9.9%	75.9%	60.0%	-13.5%
ECILC	-2.3%	34.3%	14.8%	-3.6%
REG	14.2%	11.2%	13.5%	3.0%
GSK	4.0%	72.7%	35.3%	17.8%
Industry median	7.1%	63.4%	12.4%	1.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
SDGR	10.6%	55.3%	-37.1%	-40.6%
CERT	6.4%	58.1%	24.1%	-3.6%
TDOC	-1.5%	65.6%	2.3%	-6.8%
HSTM	6.6%	64.9%	22.4%	6.4%
OMCL	7.9%	43.5%	10.2%	1.7%
PHR	14.1%	65.8%	8.6%	1.9%
Industry median	7.1%	63.4%	12.4%	1.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity313.5 M $49%
Current Liabilities169.5 M $27%
Long-term Liabilities151.1 M $24%

Key Figures

YoY change

Total Assets634.2 M $-14.6%

Total Liabilities320.6 M $-13.2%

Total Equity313.5 M $-16.1%

Cash & ST Investments399 M $-20.3%

Total Debt107 M $-7.9%

Net Debt-153.3 M $—

Peer Comparison· Health Information Services

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
SDGR	2.74	34.1%	3.09	49.4%
MSB	—	—	—	—
BHC	1.32	-1,010.0%	3.71	-8.4%
ECILC	1.73	5.9%	-0.10	81.0%
REG	0.09	-26.7%	-1.12	-1.2%
GSK	0.79	106.7%	1.35	28.4%
Industry median	1.83	22.0%	-0.01	64.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
SDGR	2.74	34.1%	3.09	49.4%
CERT	1.88	29.5%	1.49	67.8%
TDOC	2.80	77.7%	5.01	47.6%
HSTM	0.97	4.0%	-0.75	66.7%
OMCL	1.46	16.1%	-0.71	62.7%
PHR	1.76	25.8%	0.42	53.9%
Industry median	1.83	22.0%	-0.01	64.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow-145 M $-658.3%

Capital Expenditures3.4 M $-12.0%

Free Cash Flow-148.4 M $-769.5%

Dividends Paid——

Peer Comparison· Health Information Services

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
SDGR	-56.9%	-58.2%	1.3%	140.1%
MSB	-87.7%	-90.0%	2.3%	76.1%
BHC	16.2%	11.3%	4.9%	-119.7%
ECILC	13.9%	16.1%	7.1%	-391.0%
REG	31.0%	18.6%	12.4%	1,023.5%
GSK	23.0%	15.3%	7.7%	129.5%
Industry median	17.1%	13.0%	1.6%	165.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
SDGR	-56.9%	-58.2%	1.3%	140.1%
CERT	21.6%	19.7%	1.9%	-600.4%
TDOC	11.5%	10.0%	1.5%	-168.2%
HSTM	20.3%	19.2%	1.1%	318.2%
OMCL	12.7%	9.1%	3.6%	762.9%
PHR	17.7%	14.7%	3.1%	957.1%
Industry median	17.1%	13.0%	1.6%	165.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SDGR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.